These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 28183357)

  • 21. Systemic sclerosis endothelial cells recruit and activate dermal fibroblasts by induction of a connective tissue growth factor (CCN2)/transforming growth factor β-dependent mesenchymal-to-mesenchymal transition.
    Serratì S; Chillà A; Laurenzana A; Margheri F; Giannoni E; Magnelli L; Chiarugi P; Dotor J; Feijoo E; Bazzichi L; Bombardieri S; Kahaleh B; Fibbi G; Del Rosso M
    Arthritis Rheum; 2013 Jan; 65(1):258-69. PubMed ID: 22972461
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Histone Deacetylase 5 Is Overexpressed in Scleroderma Endothelial Cells and Impairs Angiogenesis via Repression of Proangiogenic Factors.
    Tsou PS; Wren JD; Amin MA; Schiopu E; Fox DA; Khanna D; Sawalha AH
    Arthritis Rheumatol; 2016 Dec; 68(12):2975-2985. PubMed ID: 27482699
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Decreased expression of the endothelial cell-derived factor EGFL7 in systemic sclerosis: potential contribution to impaired angiogenesis and vasculogenesis.
    Manetti M; Guiducci S; Romano E; Avouac J; Rosa I; Ruiz B; Lepri G; Bellando-Randone S; Ibba-Manneschi L; Allanore Y; Matucci-Cerinic M
    Arthritis Res Ther; 2013 Oct; 15(5):R165. PubMed ID: 24286167
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Scleroderma dermal microvascular endothelial cells exhibit defective response to pro-angiogenic chemokines.
    Tsou PS; Rabquer BJ; Ohara RA; Stinson WA; Campbell PL; Amin MA; Balogh B; Zakhem G; Renauer PA; Lozier A; Arasu E; Haines GK; Kahaleh B; Schiopu E; Khanna D; Koch AE
    Rheumatology (Oxford); 2016 Apr; 55(4):745-54. PubMed ID: 26705326
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Epigenetic down-regulation of microRNA-126 in scleroderma endothelial cells is associated with impaired responses to VEGF and defective angiogenesis.
    Wang Y; Sun J; Kahaleh B
    J Cell Mol Med; 2021 Jul; 25(14):7078-7088. PubMed ID: 34137496
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Domain 1 of the urokinase-type plasminogen activator receptor is required for its morphologic and functional, beta2 integrin-mediated connection with actin cytoskeleton in human microvascular endothelial cells: failure of association in systemic sclerosis endothelial cells.
    Margheri F; Manetti M; Serratì S; Nosi D; Pucci M; Matucci-Cerinic M; Kahaleh B; Bazzichi L; Fibbi G; Ibba-Manneschi L; Del Rosso M
    Arthritis Rheum; 2006 Dec; 54(12):3926-38. PubMed ID: 17133606
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Endothelial dysfunction in systemic sclerosis.
    Altorok N; Wang Y; Kahaleh B
    Curr Opin Rheumatol; 2014 Nov; 26(6):615-20. PubMed ID: 25191994
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Increased expression of aquaporin-1 in dermal fibroblasts and dermal microvascular endothelial cells possibly contributes to skin fibrosis and edema in patients with systemic sclerosis.
    Yamashita T; Asano Y; Saigusa R; Taniguchi T; Nakamura K; Miura S; Toyama T; Takahashi T; Ichimura Y; Hirabayashi M; Yoshizaki A; Miyagaki T; Sugaya M; Sato S
    J Dermatol Sci; 2019 Jan; 93(1):24-32. PubMed ID: 30270117
    [TBL] [Abstract][Full Text] [Related]  

  • 29. α-Klotho expression determines nitric oxide synthesis in response to FGF-23 in human aortic endothelial cells.
    Chung CP; Chang YC; Ding Y; Lim K; Liu Q; Zhu L; Zhang W; Lu TS; Molostvov G; Zehnder D; Hsiao LL
    PLoS One; 2017; 12(5):e0176817. PubMed ID: 28463984
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Differential expression of stromal cell-derived factor 1 and its receptor CXCR4 in the skin and endothelial cells of systemic sclerosis patients: Pathogenetic implications.
    Cipriani P; Franca Milia A; Liakouli V; Pacini A; Manetti M; Marrelli A; Toscano A; Pingiotti E; Fulminis A; Guiducci S; Perricone R; Kahaleh B; Matucci-Cerinic M; Ibba-Manneschi L; Giacomelli R
    Arthritis Rheum; 2006 Sep; 54(9):3022-33. PubMed ID: 16948134
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Fli1 deficiency contributes to the downregulation of endothelial protein C receptor in systemic sclerosis: a possible role in prothrombotic conditions.
    Saigusa R; Asano Y; Yamashita T; Taniguchi T; Takahashi T; Ichimura Y; Toyama T; Yoshizaki A; Miyagaki T; Sugaya M; Sato S
    Br J Dermatol; 2016 Feb; 174(2):338-47. PubMed ID: 26399195
    [TBL] [Abstract][Full Text] [Related]  

  • 32. α2AP regulates vascular alteration by inhibiting VEGF signaling in systemic sclerosis: the roles of α2AP in vascular dysfunction in systemic sclerosis.
    Kanno Y; Shu E; Kanoh H; Matsuda A; Seishima M
    Arthritis Res Ther; 2017 Feb; 19(1):22. PubMed ID: 28159016
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Role of Klotho in migration and proliferation of human dermal microvascular endothelial cells.
    Markiewicz M; Panneerselvam K; Marks N
    Microvasc Res; 2016 Sep; 107():76-82. PubMed ID: 27260080
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The role of endothelial cells in the vasculopathy of systemic sclerosis: A systematic review.
    Mostmans Y; Cutolo M; Giddelo C; Decuman S; Melsens K; Declercq H; Vandecasteele E; De Keyser F; Distler O; Gutermuth J; Smith V
    Autoimmun Rev; 2017 Aug; 16(8):774-786. PubMed ID: 28572048
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hypoxia-induced interstitial transformation of microvascular endothelial cells by mediating HIF-1α/VEGF signaling in systemic sclerosis.
    Mao J; Liu J; Zhou M; Wang G; Xiong X; Deng Y
    PLoS One; 2022; 17(3):e0263369. PubMed ID: 35231032
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lymphatic Endothelial-to-Myofibroblast Transition: A Potential New Mechanism Underlying Skin Fibrosis in Systemic Sclerosis.
    Rosa I; Romano E; Fioretto BS; El Aoufy K; Bellando-Randone S; Matucci-Cerinic M; Manetti M
    Cells; 2023 Sep; 12(17):. PubMed ID: 37681927
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Serum levels, tissue expression and cellular secretion of macrophage migration inhibitory factor in limited and diffuse systemic sclerosis.
    Corallo C; Paulesu L; Cutolo M; Ietta F; Carotenuto C; Mannelli C; Romagnoli R; Nuti R; Giordano N
    Clin Exp Rheumatol; 2015; 33(4 Suppl 91):S98-105. PubMed ID: 26005773
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Scleroderma Mesenchymal Stem Cells display a different phenotype from healthy controls; implications for regenerative medicine.
    Cipriani P; Marrelli A; Benedetto PD; Liakouli V; Carubbi F; Ruscitti P; Alvaro S; Pantano I; Campese AF; Grazioli P; Screpanti I; Giacomelli R
    Angiogenesis; 2013 Jul; 16(3):595-607. PubMed ID: 23413114
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inactivation of urokinase-type plasminogen activator receptor (uPAR) gene induces dermal and pulmonary fibrosis and peripheral microvasculopathy in mice: a new model of experimental scleroderma?
    Manetti M; Rosa I; Milia AF; Guiducci S; Carmeliet P; Ibba-Manneschi L; Matucci-Cerinic M
    Ann Rheum Dis; 2014 Sep; 73(9):1700-9. PubMed ID: 23852693
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impairment of endothelial cell differentiation from bone marrow-derived mesenchymal stem cells: new insight into the pathogenesis of systemic sclerosis.
    Cipriani P; Guiducci S; Miniati I; Cinelli M; Urbani S; Marrelli A; Dolo V; Pavan A; Saccardi R; Tyndall A; Giacomelli R; Cerinic MM
    Arthritis Rheum; 2007 Jun; 56(6):1994-2004. PubMed ID: 17530639
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.